Zygomatic and Pterygoid Implants Market Report 2026

The zygomatic and pterygoid implants market size has grown strongly in recent years. It will grow from $1.23 billion in 2025 to $1.3 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of severe maxillary bone loss cases, rising awareness of alternative implant solutions, growing adoption of dental implants in geriatric patients, expansion of specialized dental clinics, improvements in implant material design.

The zygomatic and pterygoid implants market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing demand for full-arch rehabilitation solutions, rising adoption of digital dentistry workflows, growing investments in advanced dental implant systems, increasing preference for graftless implant procedures, expansion of implant-supported prosthetic solutions. Major trends in the forecast period include increasing adoption of advanced implant placement techniques, rising use of digital surgical planning tools, growing demand for immediate load implant solutions, expansion of specialized dental implant training programs, enhanced focus on minimally invasive implant procedures.

The rising prevalence of oral diseases is expected to drive the growth of the zygomatic and pterygoid implants market going forward. Oral diseases encompass a variety of conditions affecting the mouth, teeth, gums, and surrounding tissues, including cavities, gum disease, oral infections, and oral cancer, often resulting from poor oral hygiene, dietary habits, or underlying health issues. The incidence of oral diseases is increasing due to factors such as inadequate oral care, diets high in sugar, limited access to dental services, and higher rates of tobacco and alcohol consumption. Zygomatic and pterygoid implants address these issues by providing stable support for dental prostheses in patients with severe bone loss, enhancing oral health, and restoring function when conventional implants are not viable. For instance, in March 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental health organization, oral diseases affected nearly 3.7 billion people worldwide, with severe periodontal disease impacting over 1 billion individuals globally, and complete tooth loss occurring in approximately 7% of adults aged 20 years and older, rising to around 23% in those aged 60 years or above. Therefore, the rising prevalence of oral diseases is fueling growth in the zygomatic and pterygoid implants market.

Key companies in the zygomatic and pterygoid implants market are focusing on introducing innovative solutions, such as metal-free implants, to serve patients with metal allergies, improve biocompatibility, and enhance long-term treatment outcomes. Metal-free implants are medical implants made entirely from non-metallic materials, such as ceramics or polymers, which are biocompatible and minimize allergic reactions, corrosion, or interference with imaging techniques like MRI. For instance, in December 2024, Pure Dental Health, a US-based leading dental practice, launched its advanced All-on-X dental implant system, featuring zygomatic and pterygoid implants to treat severe bone loss and complex dental cases. This innovative system provides patients with secure, natural-looking smiles, restoring both functionality and confidence regardless of dental complexity.

In May 2023, Henry Schein Inc., a US-based healthcare company, acquired S.I.N. Implant System for an undisclosed amount. Through this acquisition, Henry Schein aims to strengthen its dental implant portfolio and expand its global footprint in the advanced dental solutions market. S.I.N. Implant System is a Brazil-based company specializing in dental implants, including zygomatic and pterygoid implants.

Major companies operating in the zygomatic and pterygoid implants market are Straumann Holding AG, Zimmer Biomet Holding Inc., Nobel Biocare, BioHorizons Implant Systems Inc., MIS Implants Technologies Ltd., Southern Implants (Pty) Ltd., Camlog Vertriebs GmbH, Jeil Medical Corporation, Osstem Implant Co Ltd, Megagen Implant Co Ltd, Dentsply Sirona Inc, Bicon Dental Implants, Hiossen Inc, Euroteknika SAS.

North America was the largest region in the zygomatic and pterygoid implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zygomatic and pterygoid implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the zygomatic and pterygoid implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the zygomatic and pterygoid implants market by increasing costs of imported titanium materials, precision-machined implant components, surgical instruments, and digital planning equipment. Dental implant manufacturers and clinics in Europe and North America are most affected due to reliance on cross-border sourcing of specialized components, while Asia-Pacific faces cost pressure on imported premium implant systems. These tariffs are increasing procedure costs and affecting affordability for patients. However, they are also encouraging localized manufacturing, regional supplier development, and innovation in cost-optimized implant systems.

The zygomatic and pterygoid implants market research report is one of a series of new reports that provides zygomatic and pterygoid implants market statistics, including zygomatic and pterygoid implants industry global market size, regional shares, competitors with a zygomatic and pterygoid implants market share, detailed zygomatic and pterygoid implants market segments, market trends and opportunities, and any further data you may need to thrive in the zygomatic and pterygoid implants industry. This zygomatic and pterygoid implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Zygomatic and pterygoid implants are specialized dental implants anchored in the zygomatic bone (cheekbone) and pterygoid bone (near the back of the upper jaw), respectively. They are designed for patients with severe upper jaw bone loss, providing stable support for dental prostheses when conventional implants are not suitable.

The primary types of zygomatic and pterygoid implants are zygomatic implants, pterygoid implants, and combined implants. Zygomatic implants are anchored in the cheekbone to provide durable and stable support for prosthetic teeth in cases of significant upper jaw bone loss. These implants are available in various lengths, including up to 30 mm, 30-50 mm, and above 50 mm. They are applied in cases involving the maxillary sinuses, severe maxillary bone atrophy, and other conditions, and are used by end users such as dental clinics, hospital dental departments, and research institutions.

The zygomatic and pterygoid implants market consists of sales of implant abutments, guided surgery kits, and prosthetics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.